Treatment of type 2 diabetes patients with heart conditions.
Gulali AktasBurcin Meryem Atak TelRamiz TelSumeyye Buse BalciPublished in: Expert review of endocrinology & metabolism (2023)
We can suggest that hypoglycemia and extreme hyperglycemia should be avoided in acute ischemic heart conditions. Certain diabetic treatment options, especially sodium-glucose cotransporter-2 (SGLT2) inhibitors, can reduce overall cardiovascular mortality and hospitalization due to heart failure. Therefore, we suggest that physicians should choose SGLT2 inhibitors as the first-line treatment option in diabetic patients with heart failure or those who have a high risk of heart failure development. T2DM increases the risk of atrial fibrillation (AF), and metformin and pioglitazone seem to reduce the risk of AF in diabetic population.
Keyphrases
- atrial fibrillation
- type diabetes
- heart failure
- glycemic control
- catheter ablation
- oral anticoagulants
- left atrial
- direct oral anticoagulants
- wound healing
- left atrial appendage
- left ventricular
- primary care
- liver failure
- insulin resistance
- cardiac resynchronization therapy
- cardiovascular events
- hepatitis b virus
- adipose tissue
- climate change
- cardiovascular disease
- risk factors
- respiratory failure
- cerebral ischemia
- intensive care unit
- percutaneous coronary intervention
- acute respiratory distress syndrome
- aortic dissection
- metabolic syndrome
- mitral valve
- acute coronary syndrome